Greenleaf Trust’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,242
| Closed | -$276K | – | 824 |
|
|
2025
Q3 | $276K | Buy |
+2,242
| New | +$278K | ﹤0.01% | 667 |
|
|
2025
Q2 | – | Sell |
-5,100
| Closed | -$751K | – | 805 |
|
|
2025
Q1 | $751K | Sell |
5,100
-175
| -3% | -$26.7K | 0.01% | 393 |
|
|
2024
Q4 | $857K | Sell |
5,275
-22
| -0.4% | -$3.6K | 0.01% | 366 |
|
|
2024
Q3 | $863K | Buy |
5,297
+878
| +20% | +$130K | 0.01% | 371 |
|
|
2024
Q2 | $603K | Sell |
4,419
-796
| -15% | -$111K | 0.01% | 427 |
|
|
2024
Q1 | $798K | Buy |
5,215
+917
| +21% | +$137K | 0.01% | 346 |
|
|
2023
Q4 | $613K | Sell |
4,298
-853
| -17% | -$114K | 0.01% | 406 |
|
|
2023
Q3 | $675K | Buy |
5,151
+277
| +6% | +$42.1K | 0.01% | 357 |
|
|
2023
Q2 | $775K | Buy |
4,874
+1,301
| +36% | +$210K | 0.01% | 338 |
|
|
2023
Q1 | $565K | Buy |
3,573
+242
| +7% | +$36.3K | 0.01% | 410 |
|
|
2022
Q4 | $467K | Sell |
3,331
-641
| -16% | -$91K | 0.01% | 461 |
|
|
2022
Q3 | $510K | Sell |
3,972
-64
| -2% | -$9.23K | 0.01% | 394 |
|
|
2022
Q2 | $569K | Buy |
4,036
+1,626
| +67% | +$232K | 0.01% | 356 |
|
|
2022
Q1 | $335K | Sell |
2,410
-2,570
| -52% | -$394K | ﹤0.01% | 559 |
|
|
2021
Q4 | $868K | Buy |
4,980
+251
| +5% | +$41.8K | 0.01% | 278 |
|
|
2021
Q3 | $783K | Sell |
4,729
-1,703
| -26% | -$293K | 0.01% | 280 |
|
|
2021
Q2 | $1.16M | Buy |
6,432
+721
| +13% | +$132K | 0.01% | 208 |
|
|
2021
Q1 | $1.1M | Sell |
5,711
-481
| -8% | -$92.6K | 0.01% | 198 |
|
|
2020
Q4 | $1.25M | Buy |
6,192
+803
| +15% | +$166K | 0.02% | 151 |
|
|
2020
Q3 | $1.13M | Buy |
5,389
+409
| +8% | +$91.1K | 0.02% | 143 |
|
|
2020
Q2 | $1.09M | Buy |
4,980
+2,012
| +68% | +$402K | 0.02% | 144 |
|
|
2020
Q1 | $514K | Buy |
2,968
+753
| +34% | +$124K | 0.01% | 231 |
|
|
2019
Q4 | $340K | Sell |
2,215
-433
| -16% | -$64.7K | 0.01% | 373 |
|
|
2019
Q3 | $402K | Buy |
2,648
+81
| +3% | +$12.8K | 0.01% | 332 |
|
|
2019
Q2 | $393K | Sell |
2,567
-145
| -5% | -$22.1K | 0.01% | 335 |
|
|
2019
Q1 | $435K | Buy |
2,712
+44
| +2% | +$6.83K | 0.01% | 291 |
|
|
2018
Q4 | $411K | Buy |
2,668
+135
| +5% | +$21K | 0.01% | 297 |
|
|
2018
Q3 | $381K | Buy |
2,533
+144
| +6% | +$20.5K | 0.01% | 337 |
|
|
2018
Q2 | $323K | Buy |
+2,389
| New | +$295K | 0.01% | 358 |
|
|
2018
Q1 | – | Sell |
-353
| Closed | -$53K | – | 560 |
|
|
2017
Q4 | $53K | Sell |
353
-54
| -13% | -$7.35K | ﹤0.01% | 478 |
|
|
2017
Q3 | $54K | Buy |
+407
| New | +$54.7K | ﹤0.01% | 435 |
|
Other funds holding CLX
Greenleaf Trust's CLX Position: Q4 2025 in Review
Greenleaf Trust sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,242 shares — an estimated $276K sold.
Greenleaf Trust first reported a position in CLX in Q3 2017 and held it in 31 quarters. The position peaked at $1.25M in Q4 2020. 1,050 funds tracked by Wall St. Rank hold CLX as of Q4 2025.
- Greenleaf Trust reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
- Greenleaf Trust sold 2,242 Clorox shares in Q4 2025, an estimated $276K.
- Greenleaf Trust first reported a position in Clorox in Q3 2017 and held it in 31 quarters.
- Greenleaf Trust's Clorox position peaked at $1.25M in Q4 2020.
- 1,050 funds tracked by Wall St. Rank held Clorox as of Q4 2025.
Based on Greenleaf Trust's 13F filing for Q4 2025, filed 21 Jan 2026.